Epic Pharma LLC has filed an Abbreviated New Drug Application (ANDA) identified as ANDA078975 for a topical ciclopirox 8% solution. The product, listed under the brand name CICLOPIROX, is a discontinued topical solution.
The submission is classified as an original (ORIG) application, with a submission status of approved (AP) dated February 17, 2010. No reference drug or reference standard is indicated.
Regulatory UpdatesAug 30, 2026•1 min read
Epic Pharma LLC Submits ANDA078975 for Topical Ciclopirox 8% Solution (Discontinued)
Epic Pharma LLC filed ANDA078975 for a discontinued topical ciclopirox 8% solution; FDA records show the original submission was approved on 2010-02-17.
Compiled by the PharmaCountry team · Source: FDA.gov
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating